Immunoprecise Antibodies Ltd
XTSX:IPA
Immunoprecise Antibodies Ltd
XTSX:IPA
Price:
6.5
CAD
0.78%
Market Closed
Market Cap:
CA$161.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Immunoprecise Antibodies Ltd
XTSX:IPA
|
CA |
|
Australian Agricultural Company Ltd
ASX:AAC
|
AU |
|
C
|
CSL Finance Ltd
NSE:CSLFINANCE
|
IN |
|
Guizhou Salvage Pharmaceutical Co Ltd
SSE:600227
|
CN |
|
H
|
Harvey Norman Holdings Ltd
OTC:HNORY
|
AU |
|
G
|
Guangdong Investment Ltd
OTC:GGDVY
|
HK |
|
V
|
VICI Properties Inc
XMUN:1KN
|
US |
|
K
|
Kung Sing Engineering Corp
TWSE:5521
|
TW |
|
J
|
JiangSu Suyan Jingshen Co Ltd
SSE:603299
|
CN |
|
Bouygues SA
PAR:EN
|
FR |
|
C
|
Canadian Utilities Ltd
TSX:CU
|
CA |
|
S
|
Soosung Salvacion Co Ltd
KOSDAQ:084180
|
KR |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of IPA.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IPA
Multiples-Based Value
Base Case
Not Available
